Trial Profile

Assessment of 18F-Florbetaben Whole-body PET Imaging for the Comprehensive Detection of Cardiac and Extracardiac Sites of Amyloid Deposits

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 13 Feb 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Florbetaben F18 (Primary)
Indications Amyloid light-chain amyloidosis; Amyloidosis
Focus Diagnostic use
Acronyms CAPRI

Most Recent Events

11 Feb 2025 Status changed from recruiting to completed.
10 Jan 2024 Planned End Date changed from 10 May 2024 to 10 May 2025.
10 Jan 2024 Planned primary completion date changed from 30 Dec 2023 to 30 Jan 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com